论文部分内容阅读
经导管肝动脉化疗栓塞术是80年代发展的一种新疗法,为不能手术切除的中晚期肝癌患者提供了新的有效姑息疗法。同时也使这类患者或位于肝门区或紧贴大血管的肝癌瘤体缩小或局限后从而获得二步切除的机会。本文报告从1990年2月至1992年1月53例中晚期肝癌经导管肝动脉化疗栓塞术肿瘤缩小后,15例予以成功切除,现分析如下。一、临床资料本组经AFP、酶学(AKP、γ-GT、LDH及同功酶)、B超、CT和ECT等检查证实肝肿瘤巨大、较晚期、左右肝均有多发性病灶或因肿瘤位于肝门区或紧贴大血管。本组男13例,女2例;年龄32～64岁,平均为45岁。病变位于右半肝7例,中肝4例,左
Transcatheter arterial chemoembolization is a new therapy developed in the 1980s and provides a new effective palliative treatment for patients with advanced hepatocellular carcinoma who cannot be surgically resected. At the same time, this kind of patient also has the opportunity to obtain a two-step resection after the patient has been located in the hilar area or hepatocarcinoma in close proximity to the great vessels. This article reports that in the period from February 1990 to January 1992, 53 cases of advanced liver cancer were treated with transcatheter hepatic arterial chemoembolization. After 15 cases were successfully resected, they are analyzed as follows. First, clinical data in this group by AFP, enzymology (AKP, γ-GT, LDH and isozymes), B-ultrasound, CT and ECT examination confirmed liver tumors are large, more advanced, left and right liver have multiple lesions or causes The tumor is in the hilar area or close to the great vessels. The group of 13 males and 2 females; aged 32 to 64 years, an average of 45 years old. The lesions were located in the right hemiliver in 7 cases, the middle hepatic in 4 cases, and left